C134H134F13N27O14 — CID 157304080
1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-2-methyl-6-(2-propan-2-ylpyrimidin-5-yl)indazol-3-one;1-[[2-(difluoromethoxy)-5-morpholin-4-ylphenyl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(difluoromethoxy)phenyl]methyl]-5-fluoro-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[1-[(4-ethyl-3-pyridinyl)methyl]-4-(trifluoromethyl)pyrrol-3-yl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methyl-1-[[1-(pyridin-3-ylmethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]indazol-3-one (PubChem CID 157304080) has the molecular formula C134H134F13N27O14 and a molecular weight of 2593.69 g/mol. Its IUPAC name is 1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-2-methyl-6-(2-propan-2-ylpyrimidin-5-yl)indazol-3-one;1-[[2-(difluoromethoxy)-5-morpholin-4-ylphenyl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(difluoromethoxy)phenyl]methyl]-5-fluoro-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[1-[(4-ethyl-3-pyridinyl)methyl]-4-(trifluoromethyl)pyrrol-3-yl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methyl-1-[[1-(pyridin-3-ylmethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]indazol-3-one.
| Compound Name | 1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-2-methyl-6-(2-propan-2-ylpyrimidin-5-yl)indazol-3-one;1-[[2-(difluoromethoxy)-5-morpholin-4-ylphenyl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(difluoromethoxy)phenyl]methyl]-5-fluoro-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[1-[(4-ethyl-3-pyridinyl)methyl]-4-(trifluoromethyl)pyrrol-3-yl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methyl-1-[[1-(pyridin-3-ylmethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]indazol-3-one |
|---|---|
| PubChem CID | 157304080 |
| Molecular Formula | C134H134F13N27O14 |
| Molecular Weight | 2593.69 g/mol |
| Exact Mass | 2592.04 |
| IUPAC Name | 1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-2-methyl-6-(2-propan-2-ylpyrimidin-5-yl)indazol-3-one;1-[[2-(difluoromethoxy)-5-morpholin-4-ylphenyl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(difluoromethoxy)phenyl]methyl]-5-fluoro-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[1-[(4-ethyl-3-pyridinyl)methyl]-4-(trifluoromethyl)pyrrol-3-yl]methyl]-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-2-methyl-1-[[1-(pyridin-3-ylmethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]indazol-3-one |
| SMILES | CCc1ccncc1Cn1cc(Cn2c3cc(-c4cnc(C(C)(C)O)nc4)ccc3c(=O)n2C)c(C(F)(F)F)c1.C[C@@H]1CN(C(=O)CO)CCN1c1ncc(-c2cc3c(cc2F)c(=O)n(C)n3Cc2ccccc2OC(F)F)cn1.Cc1ccc(OC(F)F)c(Cn2c3cc(-c4cnc(C(C)C)nc4)ccc3c(=O)n2C)c1.Cn1c(=O)c2ccc(-c3cnc(C(C)(C)O)nc3)cc2n1Cc1cc(N2CCOCC2)ccc1OC(F)F.Cn1c(=O)c2ccc(-c3cnc(C(C)(C)O)nc3)cc2n1Cc1cn(Cc2cccnc2)cc1C(F)(F)F |
| InChI | InChI=1S/C29H29F3N6O2.C27H27F3N6O4.C27H25F3N6O2.C27H29F2N5O4.C24H24F2N4O2/c1-5-18-8-9-33-11-21(18)14-37-15-22(24(17-37)29(30,31)32)16-38-25-10-19(6-7-23(25)26(39)36(38)4)20-12-34-27(35-13-20)28(2,3)40;1-16-13-34(24(38)15-37)7-8-35(16)27-31-11-18(12-32-27)19-10-22-20(9-21(19)28)25(39)33(2)36(22)14-17-5-3-4-6-23(17)40-26(29)30;1-26(2,38)25-32-11-19(12-33-25)18-6-7-21-23(9-18)36(34(3)24(21)37)15-20-14-35(16-22(20)27(28,29)30)13-17-5-4-8-31-10-17;1-27(2,36)25-30-14-19(15-31-25)17-4-6-21-22(13-17)34(32(3)24(21)35)16-18-12-20(33-8-10-37-11-9-33)5-7-23(18)38-26(28)29;1-14(2)22-27-11-18(12-28-22)16-6-7-19-20(10-16)30(29(4)23(19)31)13-17-9-15(3)5-8-21(17)32-24(25)26/h6-13,15,17,40H,5,14,16H2,1-4H3;3-6,9-12,16,26,37H,7-8,13-15H2,1-2H3;4-12,14,16,38H,13,15H2,1-3H3;4-7,12-15,26,36H,8-11,16H2,1-3H3;5-12,14,24H,13H2,1-4H3/t;16-;;;/m.1.../s1 |
| InChIKey | BCFYKRZTTPFDCG-HOPGCNRRSA-N |
| XLogP | 20.24 |
| TPSA | 443.82 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 188 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2593.69 |
| LogP ≤ 5 | 20.24 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 40 |
| Structural Alerts | {'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'} |
|---|